This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.
- Investigator
- Jeb M Justice
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Update your location to show providers, locations, and services closest to you.
Ear, Nose and Throat Specialist (Otolaryngologist)
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.
The primary objectives of the study are: To longitudinally characterize the long-term effectiveness of DUPIXENT® through assessment of patient-reported symptoms, Health-Related Quality of Life (HRQoL) related to Chronic rhinosinusitis with nasal…
33 publications
2023
Cureus
PubMed • Publisher's site2023
The Laryngoscope
PubMed • Publisher's site2022
Journal of immunology (Baltimore, Md. : 1950)
PubMed • Publisher's site2022
Laryngoscope Investigative Otolaryngology
PubMed • Publisher's site2022
American journal of rhinology & allergy
PubMed • Publisher's site